That is why you work with a good brokerage so that direct roller take place between the former employer and the brokerage. In the meanwhile the customer never touch the 401(K) fund to avoid triggering several tax events.
Fidelity has helped to make these rollover transfer easily especially when their offices are widely available in large cities. They handled all paperwork, funds were wired and the rollover account set up within 2 weeks. Schwab also have many offices and should do equally as well.

FYI: When you do a rollover, three things happen and they're ALL bad!" —​ Ed Slott (for sure!)
Regards,
Ted
https://www.google.com/search?sxsrf=ACYBGNRLZ20LyXYOFSgZ61za6aaZeIrwIw:1567775286826&source=hp&ei=NlpyXaOwL87r5gLtirO4BA&q=+Retirement+Strategies+Rollovers+are+all+bad!+Use+only+direct+transfers+&oq=+Retirement+Strategies+Rollovers+are+all+bad!+Use+only+direct+transfers+&gs_l=psy-ab.3...3108.3108..5131...0.0..0.87.87.1......0....2j1..gws-wiz.eDcdQ83AUG4&ved=0ahUKEwijo7mIorzkAhXOtVkKHW3FDEcQ4dUDCAc&uact=5

Please read ...
https://www.member.mfopremium.com/2019/09/05/our-new-portfolio-analysis-tool/

I appreciate “laws” #11 and #13, which address self-destructive behavior.

The 13 Aug post went into the bullpen with 0 comments and has 49 views (one of which came from me looking at it just now). Perhaps the additional post will not have been a waste of time or electrons.

@BenWP - the prospectus link for the new AC fund was posted by The Shadow.
The way I read their investing strategies seems to indicate that they can use hedging when they deem it appropriate. That really isn't much different than many other funds.
From the proposed prospectus:
"Principal Investment Strategies:
The Fund seeks to achieve its investment objective by investing in healthcare related companies that the Fund’s investment sub-advisor, LifeSci Fund Management LLC (the “Sub-Advisor”) believes to have potential to appreciate in value. Under normal market conditions, the Fund will invest at least 80% of its net assets plus borrowings for investment purposes in the securities of companies in the life sciences and healthcare sectors. The Fund will invest in the equity securities, primarily common stock, of these companies and may also invest, from time to time, in exchange traded funds (“ETFs”) that primarily invest in these companies. The Fund defines life sciences and healthcare companies to include those companies that are expected to derive 50% or more of their revenue from life sciences and healthcare related products and services. These companies may include development stage companies. The Fund may invest up to 15% of the Fund’s net assets in private and other companies whose securities may have legal or contractual restrictions on resale or are otherwise illiquid such as initial public offerings, mezzanine financing offerings and other structured transactions. The Fund may invest in securities of companies of any market capitalization and may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts (“ADRs”).
The Fund concentrates its investments (i.e., invests more than 25% of its assets) in the biotech and pharmaceutical; health care facilities and services; and medical equipment and devices industries, collectively.
For hedging purposes or when the Sub-Advisor anticipates significant price changes due to company or market moving events, the Fund may also invest in inverse ETFs and purchase and sell call and put options on equity securities of life sciences and healthcare companies."

I worked emergency services during Hurricane Andrew in S.Florida back in 1992. Hurricanes are NOT to be trifled with!!!
#SharpieGate was pathetically amusing on Twitter today.
I wonder if he was hoping to use the storm's (alleged) impact to try and funnel some 'disaster aid' money in an effort to buy votes in order to keep red senate seats?
Tweety isn't even TRYING to lie well anymore, it seems.....

@MJG: For your information I have linked Morgan's current article for over a year. He was recently interviewed on M*'s The Long View Podcast.
Regards,
Ted
The Laws Of Investing
https://www.mutualfundobserver.com/discuss/discussion/51984/morgan-housel-the-laws-of-investing#latest
M*'s The Long View
https://www.mutualfundobserver.com/discuss/discussion/49997/m-the-long-view-guest-morgan-housel-podcast/p1

Hi Guys,
Here is a Link to a rather lengthy but powerful article that presents the author’s view on 17 investment laws he invented:
https://www.collaborativefund.com/blog/the-laws-of-investing/
Morgan Housel is an informed writer. This is only a single man’s opinion, but his body of work is impressive. I especially liked his Law 9 which states: “ Big results are driven by tail events, so winning while losing much of the time is normal. “. A few big winners will overwhelm many smaller losing investments.There is much wisdom in that Law as well as many others that he presents.
Although reading the article will cost time, I believe the reward is worth the effort. Just my opinion. Good luck to all.
Best Regards

FYI: You can’t make this up.
Newell Brands , the company that makes Sharpie markers, got an overnight surge in popularity following President Trump’s use of an apparently altered weather map to support his assertion that Alabama was in the path of Hurricane Dorian.
Regards,
Ted
https://www.wsj.com/articles/sharpie-makes-its-mark-11567698099
Frank Sinatra: Stars Fell On Alabama:

FYI: American Funds’ multimanager approach has long served its equity investors well--and should continue to do so, thanks to parent Capital Group’s strong, results-oriented investing culture. Indeed, 13 of the 14 American Funds equity offerings with a forward-looking Morningstar Analyst Rating are medalists, including 10 Gold-rated funds.
Regards,
Ted
https://www.morningstar.com/articles/944346/understanding-american-funds-equity-lineup

DF Dent Mid Cap (DFDMX) is new to my portfolio this year and this is the company's first annual report I've received.
https://s3.amazonaws.com/221-DF_DENT_FUNDS/221-ANR-0619.pdf
It's an impressive document on many counts. Their discussion of indexing vs. active management is really insightful and gave me a better understanding of the consequences of choosing one or the other, including an ominous prediction of what might happen to the market if all the new index money suddenly wanted to get out the door at the same time. Dent claims they would not be much affected by such an event, but I took that with a grain of salt. The Dent managers of their three strategies explain in detail rarely found in other annual reports how they initiate positions, how they prune, and how they re-balance and why. I followed the mid-cap fund for a while after Kipplinger put it on its list of "25," and I did the same after Barron's highlighted the Premier Growth Fund. Both endorsements, according to the report, resulted in money flowing in. DF Dent is a Baltimore firm in very good company: TRP, Brown Capital, and Brown Advisory hang out there, too. Most annual reports I read are pablum; this one has flavor and substance.

Oh ... Where is Jeffrey Saut? Seems, Raymond James retired him! Wonder what his thoughts are?
https://www.cnbc.com/video/2019/08/09/strategist-the-lows-are-in-for-the-us-market.html
For now ... I'm going to roll with Saut's thinking.
Old_Skeet

@Junkster
Regarding the new fund effect: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1101615

I cite detailed studies in my book by the Charles Schwab Center for Investment Research and also by Kobren Insight Group on the validity of the new funds effect. Also provide real time trade results on the new funds effect. Of course this was from what is now a mostly bygone era. But the effect is still there in some cases. A recent example being EIXIX - new fund in a hot sector. I would hate to think where I might be now had it not been for exploiting the new funds effect in the late 90s.
You must bring out the worst in me as I have never mentioned my book in all my years on this forum. I detest those that pander their books on forums. Most especially that master marketeer of his 1001 investment books on the Bogleheads site.
https://www.amazon.com/How-Trade-Living-Gary-Smith/dp/0471355143

@PRESSmUP and @catch22, Agree. Info on her Twitter are more concise than the longer articles she presented in Schwab.

https://www.schwab.com/resource-center/insights/content/market-perspective

Today the market is up (risk off) since China and US agree to talk again in October.

https://www.fidelity.com/news/article/top-news/201909050115RTRSNEWSCOMBINED_KCN1VQ061-OUSBS_1

No major change on our end.

@Junkster
Regarding the new fund effect: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1101615

IOFAX , the A-shares which I own, have an exp ratio of 1.75%. What is the difference if it clearly performs more consistent with higher returns than say a fund like PONAX? Ride the momentum until it ain't. When it ain't, move on.
I was happy to heed Junksters suggestion. Been my only domestic bond fund for a while.

At the beginning of every mutual fund prospectus is generally a little seemingly innocuous sentence: Past performance is no guarantee of future results. So what if it's been hot in the past? The only question that matters to anyone reading this right now is--Will it continue to be? Time and again, fees or all-in costs have been the strongest most consistent indicator of future performance. Are low costs always the best predictor? No, that's why people come to this site. But Morningstar is absolutely right to ding this fund for charging a 1.5% expense ratio on $3.3 billion in assets when bond funds that specialize in non-agency debt can be had for much less.

To each their own. Over two and a half years in March 2017 here at MFO I said IOFIX has been a “wonder to behold since inception”. In 50+ years in the game have never once looked at a fund’s expense ratio. Long ago in my book I wrote about exploiting the new fund effect. I used actual real money trading examples from new funds from Strong and INVESCO. I would have hated to have seen the expense ratios of these new funds.

J P Morgan says now is the time to add risk back into your portfolio and buy stocks. You can read more about this in the below linked article.
https://www.bloomberg.com/news/articles/2019-09-02/jpmorgan-says-it-s-finally-time-to-buy-stocks-despite-trade-woes

Not sure if you're a Twitter user, but Liz Ann Sonders lays things out in a data-rich set of charts in a way you wont even see within the Schwab website.
Her latest charts of the ISM mfg index wouldn't lend itself to a risk on play.

At the beginning of every mutual fund prospectus is generally a little seemingly innocuous sentence: Past performance is no guarantee of future results. So what if it's been hot in the past? The only question that matters to anyone reading this right now is--Will it continue to be? Time and again, fees or all-in costs have been the strongest most consistent indicator of future performance. Are low costs always the best predictor? No, that's why people come to this site. But Morningstar is absolutely right to ding this fund for charging a 1.5% expense ratio on $3.3 billion in assets when bond funds that specialize in non-agency debt can be had for much less.